In this section
Kristen Ahlschwede, PhD
Dr. Kristen Ahlschwede, Assistant Professor of Pharmaceutical Sciences, joined the college in 2015. Dr. Ahlschwede received her BS in biomedical sciences from the University of South Florida in 2007. She immediately went on to complete a master’s degree in pharmaceutical sciences in 2010 the College of Pharmacy and Pharmaceutical Sciences from Florida A&M University, followed by her PhD in pharmaceutical sciences from the same university in 2013. Dr. Ahlschwede completed her post-doctoral fellowships in pharmacokinetics at the College of Pharmacy at University of Minnesota and the U.S. Food and Drug Administration, National Center for Toxicological Research.
- Pharmaceutics I
- Pharmaceutics II
- Pharmaceutical Calculations
- Non-sterile Compounding Advanced Pharmaceutical Compounding (Elective)
Areas of Expertise
- Drug Delivery
- Nanotechnology and Nanomedicine
- Drug targeting to the brain
- Formulations for parenteral use
- Protein conjugates to prevent the formation of an adherent Staphylococcus epidermidis biofilm.
- Formulation and characterization of novel products to prevent tooth decay.
- Outcome based research projects
Ahlschwede KM, Curran GL, Rosenberg JT, Grant SC, Sarkar G, Jenkins RB, et al. Cationic carrier peptide enhances cerebrovascular targeting of nanoparticles in Alzheimer’s disease brain. Nanomedicine: Nanotechnology, Biology, and Medicine. Feb 2019;16.
Swaminathan SK, Ahlschwede KM, Sarma V, Curran GL, Omtri R, Decklever T, et al. Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain. J Cereb Blood Flow Metab. May 2018;38(5).
Agyare E, Jaruszewski KM, Curran GL, Rosenberg JT, Grant SC, Lowe VJ, Ramakrishnan S, Paravastu A, Poduslo JF, Kandimalla KK. Engineering theranostic nanovehicles capable of targeting cerebrovascular amyloid deposits. Journal of Controlled Release, 2014, 185, 121-129, 2014.
Jaruszewski KM, Curran GL, Swaminathan SK, Rosenberg JT, Ramakrishnan S, Lowe VJ, Grant SC, Poduslo JF, Kandimalla KK. Multimodal nanoprobes to target cerebrovascular amyloid. Biomaterials, 35(6), 1967-76, 2014.